Want to see IN:MUKKA full AI Analyst Report?
Mukka Proteins Limited (MUKKA) AI Stock Analysis
Mukka Proteins Limited
(NSE:MUKKA)
The overall score is constrained primarily by financial risks: while Mukka Proteins is growing rapidly and remains profitable, margin pressure, heavy reliance on debt, and persistently negative operating and free cash flows materially weaken its quality profile. Technicals are supportive, with a strong uptrend and positive momentum, but stretched indicators raise near-term volatility and correction risk. Valuation at a mid-teens P/E without a disclosed dividend is neither clearly cheap nor expensive, leaving the risk-reward balance in a cautiously neutral zone.
Mukka Proteins Limited (MUKKA) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 7.31B
- Dividend Yield
- ―
- Average Volume (3M)
- 81.61K
- Price to Earnings (P/E)
- 10.5
- Beta (1Y)
- 0.90
- Revenue Growth
- 76.01%
- EPS Growth
- 59.13%
- Country
- India
- Employees
- 358
- Sector
- General
- Sector Strength
- 55
- Industry
- Packaged Foods
Mukka Proteins Limited Business Overview & Revenue Model
Company Description
Mukka Proteins Limited, based in Mangaluru, India, operates as a prominent manufacturer and supplier of protein products, extending its reach both domestically and internationally. The company specializes in a variety of fish-derived offerings, inclu...
How the Company Makes Money
Mukka Proteins makes money mainly by selling marine protein and lipid ingredients produced from processing fish and fish by-products. Its core revenue stream is the sale of fish meal (a high-protein ingredient used as an input in aquaculture and othe...
Mukka Proteins Limited Financial Statement Overview
Summary
Strong revenue and net income growth are offset by recent margin compression, rising leverage, and persistently weak operating and free cash flows, resulting in a mid-range financial strength score.
Income Statement
72PositiveBalance Sheet
63PositiveCash Flow
28Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.70B | 14.49B | 10.06B | 13.80B | 11.56B | 7.66B |
| Gross Profit | 3.02B | 2.23B | 2.32B | 1.69B | 1.34B | 799.87M |
| EBITDA | 1.71B | 1.45B | 948.84M | 1.22B | 962.04M | 550.04M |
| Net Income | 691.27M | 520.58M | 464.59M | 700.52M | 440.75M | 242.08M |
Balance Sheet | ||||||
| Total Assets | 0 | 16.21B | 10.76B | 9.41B | 5.75B | 3.92B |
| Cash, Cash Equivalents and Short-Term Investments | 604.29M | 604.29M | 30.75M | 944.38M | 265.48M | 180.42M |
| Total Debt | 0 | 7.79B | 4.53B | 3.65B | 2.62B | 1.75B |
| Total Liabilities | -5.29B | 10.92B | 6.20B | 5.32B | 4.19B | 2.97B |
| Stockholders Equity | 5.29B | 4.99B | 4.41B | 3.96B | 1.34B | 898.23M |
Cash Flow | ||||||
| Free Cash Flow | 0 | -2.97B | -1.36B | -1.68B | -737.46M | -63.29M |
| Operating Cash Flow | 0 | -1.59B | -1.12B | -1.50B | -563.28M | 48.08M |
| Investing Cash Flow | 0 | -1.46B | -349.86M | -475.94M | -33.25M | -122.84M |
| Financing Cash Flow | 0 | 3.15B | 555.53M | 2.66B | 746.65M | 158.58M |
Mukka Proteins Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MUKKA, the sentiment is Negative. The current price of 24.60 is below the 20-day moving average (MA) of 26.19, below the 50-day MA of 27.15, and above the 200-day MA of 24.13, indicating a neutral trend. The MACD of -0.74 indicates Positive momentum. The RSI at 40.34 is Neutral, neither overbought nor oversold. The STOCH value of 17.51 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MUKKA.
Mukka Proteins Limited Peers Comparison
Overall Rating
IN:HATSUN75Outperform
IN:PARAGMILK75Outperform
IN:SKMEGGPROD68Neutral
IN:AVANTIFEED66Neutral- IN:MUKKA59.6Neutral
IN:MKPL47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:HATSUN | 75Outperform | INR 221.90B | 61.70 | ― | 1.00% | 17.90% | 9.78% |
| IN:PARAGMILK | 75Outperform | INR 29.22B | 22.12 | ― | 0.47% | 10.91% | 3.74% |
| IN:SKMEGGPROD | 68Neutral | INR 10.24B | 9.76 | ― | 0.64% | 21.31% | 89.98% |
| IN:AVANTIFEED | 66Neutral | INR 89.82B | 16.46 | ― | 1.52% | 11.35% | -8.27% |
| IN:MUKKA | 60Neutral | INR 7.38B | 10.54 | ― | ― | 76.01% | 59.13% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:MKPL | 47Neutral | INR 1.48B | 29.54 | ― | ― | 17.76% | -50.16% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:MUKKA | Mukka Proteins Limited | 24.60 | -0.47 | -1.87% | |
| IN:AVANTIFEED | Avanti Feeds Limited | 659.25 | -38.14 | -5.47% | |
| IN:HATSUN | Hatsun Agro Product Limited | 996.20 | -65.11 | -6.14% | |
| IN:MKPL | M K Proteins Limited | 3.93 | -2.80 | -41.60% | |
| IN:PARAGMILK | Parag Milk Foods Ltd. | 232.80 | -85.91 | -26.96% | |
| IN:SKMEGGPROD | SKM Egg Products Export (India) Ltd. | 194.50 | -17.87 | -8.42% |
Mukka Proteins Limited Corporate Events
Mukka Proteins Shareholders Clear All Resolutions at 16th AGM via E-Voting
Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026, via video conference in compliance with the Companies Act and relevant regulatory circulars. The company reported that all resolutions set out in the AGM notice, inclu...
Mukka Proteins Holds 16th AGM via Virtual Platform with Broad Shareholder Participation
Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026 via video conferencing and other audio-visual means, in line with MCA and SEBI circulars. The proceedings were deemed to be conducted at the company’s registered...
Mukka Proteins Extends Tenure of Independent Directors and Top Executives at AGM
At its 16th Annual General Meeting on 10 September 2026, Mukka Proteins Limited secured shareholder approval to reappoint three non-executive independent directors for second five-year terms commencing in January 2027. The move reinforces board conti...
Mukka Proteins Wins EU Certification for Eco Sphere Organic Fertilizer
Mukka Proteins Limited has received an EU – Inputs Attestation from ECOCERT S.A.S., France, confirming that its Eco Sphere Organic Fertilizer is suitable for use in organic farming under specific EU programme conditions. The certification, issu...
Mukka Proteins Sets Fully Virtual 16th AGM for 10 September
Mukka Proteins Limited has announced that its 16th Annual General Meeting will be held on 10 September 2026 at 3:00 p.m. IST through video conferencing and other audio-visual means, in line with regulatory provisions allowing virtual shareholder meet...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026